Screening of Monocyte Chemoattractant Protein-1-Induced Chemotaxis Inhibitors from Medicinal Herbs |
Lee, Seung-Woong
(Laboratory of Lipid Metabolism, Korea Research Institute of Bioscience and Biotechnology)
Kwon, Oh-Eok (Laboratory of Lipid Metabolism, Korea Research Institute of Bioscience and Biotechnology) Chung, Mi-Yeon (Laboratory of Lipid Metabolism, Korea Research Institute of Bioscience and Biotechnology) Kim, Young-Ho (College of Pharmacy, Chungnam National University) Lee, Hyun-Sun (Laboratory of Lipid Metabolism, Korea Research Institute of Bioscience and Biotechnology) Kim, Young-Kook (Laboratory of Lipid Metabolism, Korea Research Institute of Bioscience and Biotechnology) Rho, Mun-Chual (Laboratory of Lipid Metabolism, Korea Research Institute of Bioscience and Biotechnology) |
1 | Ross, R. (1995) Cell biology of atherosclerosis. Annu. Rev. Physiol. 57: 791-804 DOI PUBMED ScienceOn |
2 | Boring, L., Gosling, J., Cleary, M. and Charo, I. F. (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897 DOI ScienceOn |
3 | Gerszten, R. E., Lim, Y. C., Ding, H. T., Snapp, K., Kansas, G. Dichek, D. A., Cabanas, C., Francisco, S. M., Gimbrone Jr, M. A., Rosenzweig, A. and Lusinskas, F. W. (1998) Adhesion of Monocytes to Vascular Cell Adhesion Molecule-1-Transduced Human Endothelial Cells : Implications for Atherogenesis. Circ. Res. 82: 871-878 DOI ScienceOn |
4 | Horuk, R. and Ng, H. P. (2000) Chemokine receptor antagonists. Med. Res. Rev. 20: 155-168 DOI ScienceOn |
5 | Harrington, J. R. (2000) The role of MCP-l in atherosclerosis. Stem Cells 18: 65-66 DOI PUBMED ScienceOn |
6 | Taub, D. D. (1996) Chemokine-leukocyte interactions. Cytokine Growth Factor Rev. 7: 355-376 DOI PUBMED ScienceOn |
7 | Tumer, S. J., Domin, J., Waterfield, M. D., Ward, S. G. and Westwick, J. (1998) The CC Chemokine Monocyte Chemoatactic Peptide-l Activates both the Class I p85/p110 Phosphatidylinositol 3-kinase and the Class II PI3K-C2. J. Bio. Chem. 273: 25987-25995 DOI |
8 | Baggiolini, M. and Loetscher, P. (2000) Chemokines in inflammation and immunity. Immunol. Today 21: 418-420 DOI ScienceOn |
9 | Seino, Y., Ikeda, U., Sekiguchi, H., Morita, M., Konishi, K., Kasahara, T. and Shimada, K. (1995) Expression of monocyte chemoattactant protien-l in vascularb tissue. Cytokine 6: 575-579 |
10 | Takeya, M., Yoshimura, T., Leonard, E. J. and Takahashi, K. (1993) Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol. 5: 534-539 |
11 | Gosling, J., Slaymaker, S., Gu, L., Tseng, S., Zlot, C. H., Young, S. G., Rollins, B. J. and Charo, I. F. (1999) MCP-l deficiency reduces susceptibility to atheroslcerosis in mice that overexpress human apolipoprotein B. J. Ctin. Invest. 103: 773-778 DOI ScienceOn |
12 | Power, C. A. and Proudfoot, A. E. (2001) The chemokine system: novel broad-spectrum therapeutic targets. Curr. Opin. Pharmacol. 1: 417-424 DOI ScienceOn |
13 | Gu, L., Okada, Y., Clinton, S. K., Gerard, C., sukhova, G. K., Libby, P. and Rollins, B. J. (1998) Absence of monocyte chemoattractant protein-1 reduces atheroslceorsis in low density lipoprotein receptor-deficient mice. Mol. Cett 2: 275-281 |
14 | Nelken, N. A., Coughlin, S. R., Gordon, D. and Wilcox, J. N. (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 4: 1121-1127 |